Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2022-05-05 Purchase | 2022-05-09 7:20 pm | Kymera Therapeutics Inc. | KYMR | BVF PARTNERS L P BIOTECHNOLOGY VALUE FUND L P BVF I GP LLC BIOTECHNOLOGY VALUE FUND II LP BVF II GP LLC Biotechnology Value Trading Fund OS LP BVF Partners OS Ltd. BVF GP HOLDINGS LLC BVF INC LAMPERT MARK N See Remarks and Footnotes | 250,000 | $19.46 | $4,865,365 | 276,925 (Indirect Direct) | View |
| 2022-01-27 Purchase | 2022-01-31 7:44 pm | Kymera Therapeutics Inc. | KYMR | BVF PARTNERS L P BIOTECHNOLOGY VALUE FUND L P BVF I GP LLC BIOTECHNOLOGY VALUE FUND II LP BVF II GP LLC Biotechnology Value Trading Fund OS LP BVF Partners OS Ltd. BVF GP HOLDINGS LLC BVF INC LAMPERT MARK N See Remarks | 130,309 | $38.96 | $5,076,473 | 1,664,653 (Indirect Direct) | View |
| 2022-01-24 Purchase | 2022-01-26 7:43 pm | Kymera Therapeutics Inc. | KYMR | BVF PARTNERS L P BIOTECHNOLOGY VALUE FUND L P BVF I GP LLC BIOTECHNOLOGY VALUE FUND II LP BVF II GP LLC Biotechnology Value Trading Fund OS LP BVF Partners OS Ltd. BVF GP HOLDINGS LLC BVF INC LAMPERT MARK N See Remarks | 272,767 | $37.76 | $10,300,637 | 1,612,471 (Indirect Direct) | View |
| 2022-01-12 Sale | 2022-01-14 5:01 pm | Kymera Therapeutics Inc. | KYMR | Jacobs Bruce N. CFO | 15,000 | $51.85 | $777,684 | 54,488 (Direct) | View |
| 2022-01-10 Sale | 2022-01-12 7:30 pm | Kymera Therapeutics Inc. | KYMR | Mainolfi Nello CEO | 48,000 | $53.31 | $2,558,742 | 2,229,186 (Direct) | View |
| 2021-12-03 Sale | 2021-12-03 6:43 pm | Kymera Therapeutics Inc. | KYMR | Jacobs Bruce N. CFO | 10,000 | $53.56 | $535,637 | 207,413 (Direct) | View |
| 2021-11-01 Sale | 2021-11-02 6:45 pm | Kymera Therapeutics Inc. | KYMR | Gollob Jared Chief Medical Officer | 57,493 | $62.16 | $3,573,658 | 317,284 (Direct) | View |
| 2021-10-08 Sale | 2021-10-12 4:30 pm | Kymera Therapeutics Inc. | KYMR | Mainolfi Nello CEO | 48,000 | $56.34 | $2,704,536 | 528,105 (Direct) | View |
| 2021-09-03 Sale | 2021-09-03 5:57 pm | Kymera Therapeutics Inc. | KYMR | Jacobs Bruce N. CFO | 10,000 | $60.12 | $601,180 | 217,155 (Direct) | View |
| 2021-08-27 Sale | 2021-08-27 4:55 pm | Kymera Therapeutics Inc. | KYMR | Chesworth Richard Chief Scientific Officer | 33,779 | $60.12 | $2,030,864 | 263,340 (Direct) | View |
| 2021-08-17 Sale | 2021-08-19 4:30 pm | Kymera Therapeutics Inc. | KYMR | Chesworth Richard Chief Scientific Officer | 54,000 | $50.37 | $2,720,182 | 297,119 (Direct) | View |
| 2021-08-11 Sale | 2021-08-12 10:43 am | Kymera Therapeutics Inc. | KYMR | Booth Bruce Director | 242,133 | $61 | $14,770,113 | 6,875,698 (Indirect) | View |
| 2021-08-11 Sale | 2021-08-12 10:42 am | Kymera Therapeutics Inc. | KYMR | ATLAS VENTURE ASSOCIATES X L.P. Atlas Venture Associates X LLC 10% Owner | 242,133 | $61 | $14,770,113 | 5,763,012 (Indirect Direct) | View |
| 2021-08-03 Sale | 2021-08-05 4:14 pm | Kymera Therapeutics Inc. | KYMR | Mainolfi Nello CEO | 6,706 | $60.06 | $402,786 | 606,686 (Direct) | View |
| 2021-07-29 Sale | 2021-08-02 5:53 pm | Kymera Therapeutics Inc. | KYMR | Mainolfi Nello CEO | 30,415 | $60.25 | $1,832,371 | 755,683 (Direct) | View |
| 2021-07-26 Sale | 2021-07-28 4:57 pm | Kymera Therapeutics Inc. | KYMR | Mainolfi Nello CEO | 12,879 | $60.15 | $774,646 | 683,755 (Direct) | View |
| 2021-07-08 Sale | 2021-07-09 4:30 pm | Kymera Therapeutics Inc. | KYMR | Mainolfi Nello CEO | 48,000 | $49.7 | $2,385,628 | 578,924 (Direct) | View |
| 2021-07-01 Purchase | 2021-07-06 6:40 pm | Kymera Therapeutics Inc. | KYMR | BVF PARTNERS L P BIOTECHNOLOGY VALUE FUND L P BVF I GP LLC BIOTECHNOLOGY VALUE FUND II LP BVF II GP LLC Biotechnology Value Trading Fund OS LP BVF Partners OS Ltd. BVF GP HOLDINGS LLC BVF INC LAMPERT MARK N See Remarks | 544,166 | $47 | $25,575,802 | 268,728 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2022-05-04 Exercise | 2022-05-04 09:02 am | N/A 2028-10-31 | Kymera Therapeutics Inc. | KYMR | Gollob Jared Chief Medical Officer | 20,000 | $0 | 196,076 (Direct) | View |
| 2022-05-04 Exercise | 2022-05-04 09:02 am | N/A N/A | Kymera Therapeutics Inc. | KYMR | Gollob Jared Chief Medical Officer | 9,792 | $2.08 | 196,076 (Direct) | View |
| 2022-05-04 Exercise | 2022-05-04 09:02 am | N/A N/A | Kymera Therapeutics Inc. | KYMR | Gollob Jared Chief Medical Officer | 10,208 | $1.31 | 196,076 (Direct) | View |
| 2022-05-03 Exercise | 2022-05-03 7:27 pm | N/A 2029-05-22 | Kymera Therapeutics Inc. | KYMR | Mainolfi Nello CEO | 20,000 | $0 | 548,623 (Direct) | View |
| 2022-05-03 Exercise | 2022-05-03 7:27 pm | N/A N/A | Kymera Therapeutics Inc. | KYMR | Mainolfi Nello CEO | 20,000 | $2.08 | 548,623 (Direct) | View |
| 2022-05-03 Exercise | 2022-05-03 7:26 pm | N/A 2029-08-28 | Kymera Therapeutics Inc. | KYMR | Jacobs Bruce N. CFO | 20,000 | $0 | 220,713 (Direct) | View |
| 2022-05-03 Exercise | 2022-05-03 7:26 pm | N/A N/A | Kymera Therapeutics Inc. | KYMR | Jacobs Bruce N. CFO | 20,000 | $2.08 | 220,713 (Direct) | View |
| 2021-06-16(A) Option Award | 2022-04-15 4:15 pm | N/A 2031-06-15 | Kymera Therapeutics Inc. | KYMR | Ridloff Elena Director | 10,459 | $0 | 10,459 (Direct) | View |
| 2021-03-12(A) Option Award | 2022-04-15 4:15 pm | N/A 2031-03-11 | Kymera Therapeutics Inc. | KYMR | Ridloff Elena Director | 20,919 | $0 | 20,919 (Direct) | View |
| 2022-03-01 Option Award | 2022-03-03 4:31 pm | N/A 2032-02-29 | Kymera Therapeutics Inc. | KYMR | Mainolfi Nello CEO | 275,100 | $0 | 275,100 (Direct) | View |
| 2022-03-01 Option Award | 2022-03-03 4:30 pm | N/A 2032-02-29 | Kymera Therapeutics Inc. | KYMR | Jacobs Bruce N. CFO | 93,300 | $0 | 120,814 (Direct) | View |
| 2022-03-01 Option Award | 2022-03-03 4:30 pm | N/A 2032-02-29 | Kymera Therapeutics Inc. | KYMR | Gollob Jared Chief Medical Officer | 88,400 | $0 | 113,057 (Direct) | View |
| 2022-03-01 Option Award | 2022-03-03 4:30 pm | N/A 2032-02-29 | Kymera Therapeutics Inc. | KYMR | Caughey Elaine Chief Business Officer | 48,000 | $0 | 48,000 (Direct) | View |
| 2022-01-18 Option Award | 2022-01-19 5:35 pm | N/A 2032-01-17 | Kymera Therapeutics Inc. | KYMR | MARAGANORE JOHN Director | 24,000 | $0 | 24,000 (Direct) | View |
| 2022-01-14 Exercise | 2022-01-14 5:30 pm | N/A 2029-05-22 | Kymera Therapeutics Inc. | KYMR | Mainolfi Nello CEO | 10,000 | $0 | 548,623 (Direct) | View |
| 2022-01-14 Exercise | 2022-01-14 5:30 pm | N/A N/A | Kymera Therapeutics Inc. | KYMR | Mainolfi Nello CEO | 10,000 | $2.08 | 548,623 (Direct) | View |
| 2022-01-14 Exercise | 2022-01-14 5:15 pm | N/A 2029-08-28 | Kymera Therapeutics Inc. | KYMR | Jacobs Bruce N. CFO | 10,000 | $0 | 207,413 (Direct) | View |
| 2022-01-14 Exercise | 2022-01-14 5:15 pm | N/A N/A | Kymera Therapeutics Inc. | KYMR | Jacobs Bruce N. CFO | 10,000 | $2.08 | 207,413 (Direct) | View |
| 2022-01-12 Exercise | 2022-01-14 5:01 pm | N/A 2029-08-28 | Kymera Therapeutics Inc. | KYMR | Jacobs Bruce N. CFO | 15,000 | $0 | 54,488 (Direct) | View |
| 2022-01-12 Exercise | 2022-01-14 5:01 pm | N/A N/A | Kymera Therapeutics Inc. | KYMR | Jacobs Bruce N. CFO | 15,000 | $2.08 | 54,488 (Direct) | View |
| 2022-01-10 Exercise | 2022-01-12 7:30 pm | N/A 2029-11-13 | Kymera Therapeutics Inc. | KYMR | Mainolfi Nello CEO | 48,000 | $0 | 2,229,186 (Direct) | View |
| 2022-01-10 Exercise | 2022-01-12 7:30 pm | N/A N/A | Kymera Therapeutics Inc. | KYMR | Mainolfi Nello CEO | 48,000 | $2.08 | 2,229,186 (Direct) | View |
| 2021-12-16 Exercise | 2021-12-16 4:49 pm | N/A 2029-05-22 | Kymera Therapeutics Inc. | KYMR | Mainolfi Nello CEO | 8,000 | $0 | 548,623 (Direct) | View |
| 2021-12-16 Exercise | 2021-12-16 4:49 pm | N/A N/A | Kymera Therapeutics Inc. | KYMR | Mainolfi Nello CEO | 8,000 | $2.08 | 548,623 (Direct) | View |
| 2021-12-03 Exercise | 2021-12-03 6:43 pm | N/A 2029-08-28 | Kymera Therapeutics Inc. | KYMR | Jacobs Bruce N. CFO | 10,000 | $0 | 207,413 (Direct) | View |
| 2021-12-03 Exercise | 2021-12-03 6:43 pm | N/A N/A | Kymera Therapeutics Inc. | KYMR | Jacobs Bruce N. CFO | 10,000 | $2.08 | 207,413 (Direct) | View |
| 2021-11-23 Exercise | 2021-11-23 4:59 pm | N/A 2029-08-28 | Kymera Therapeutics Inc. | KYMR | Jacobs Bruce N. CFO | 10,000 | $0 | 217,155 (Direct) | View |
| 2021-11-23 Exercise | 2021-11-23 4:59 pm | N/A N/A | Kymera Therapeutics Inc. | KYMR | Jacobs Bruce N. CFO | 10,000 | $2.08 | 217,155 (Direct) | View |
| 2021-11-01 Exercise | 2021-11-02 6:45 pm | N/A 2028-10-31 | Kymera Therapeutics Inc. | KYMR | Gollob Jared Chief Medical Officer | 39,603 | $0 | 317,284 (Direct) | View |
| 2021-11-01 Exercise | 2021-11-02 6:45 pm | N/A N/A | Kymera Therapeutics Inc. | KYMR | Gollob Jared Chief Medical Officer | 19,603 | $2.08 | 317,284 (Direct) | View |
| 2021-11-01 Exercise | 2021-11-02 6:45 pm | N/A N/A | Kymera Therapeutics Inc. | KYMR | Gollob Jared Chief Medical Officer | 20,000 | $1.31 | 317,284 (Direct) | View |
| 2021-10-08 Exercise | 2021-10-12 4:30 pm | N/A 2029-11-13 | Kymera Therapeutics Inc. | KYMR | Mainolfi Nello CEO | 48,000 | $0 | 528,105 (Direct) | View |
| 2021-10-08 Exercise | 2021-10-12 4:30 pm | N/A N/A | Kymera Therapeutics Inc. | KYMR | Mainolfi Nello CEO | 48,000 | $2.08 | 528,105 (Direct) | View |
| 2021-09-03 Exercise | 2021-09-03 5:57 pm | N/A N/A | Kymera Therapeutics Inc. | KYMR | Jacobs Bruce N. CFO | 10,000 | $2.08 | 217,155 (Direct) | View |
| 2021-09-03 Option Award | 2021-09-03 5:57 pm | N/A 2029-08-28 | Kymera Therapeutics Inc. | KYMR | Jacobs Bruce N. CFO | 10,000 | $0 | 217,155 (Direct) | View |
| 2021-08-27 Exercise | 2021-08-27 4:55 pm | N/A N/A | Kymera Therapeutics Inc. | KYMR | Chesworth Richard Chief Scientific Officer | 33,779 | $20 | 263,340 (Direct) | View |
| 2021-08-27 Exercise | 2021-08-27 4:55 pm | N/A 2030-08-19 | Kymera Therapeutics Inc. | KYMR | Chesworth Richard Chief Scientific Officer | 33,779 | $0 | 263,340 (Direct) | View |
| 2021-08-17 Exercise | 2021-08-19 4:30 pm | N/A N/A | Kymera Therapeutics Inc. | KYMR | Chesworth Richard Chief Scientific Officer | 54,000 | $20 | 297,119 (Direct) | View |
| 2021-08-17 Exercise | 2021-08-19 4:30 pm | N/A 2030-08-19 | Kymera Therapeutics Inc. | KYMR | Chesworth Richard Chief Scientific Officer | 54,000 | $0 | 297,119 (Direct) | View |
| 2021-08-19 Exercise | 2021-08-19 4:30 pm | N/A 2029-05-22 | Kymera Therapeutics Inc. | KYMR | Mainolfi Nello CEO | 12,000 | $0 | 548,623 (Direct) | View |
| 2021-08-19 Exercise | 2021-08-19 4:30 pm | N/A N/A | Kymera Therapeutics Inc. | KYMR | Mainolfi Nello CEO | 12,000 | $2.08 | 548,623 (Direct) | View |
| 2021-08-03 Exercise | 2021-08-05 4:14 pm | N/A 2029-11-13 | Kymera Therapeutics Inc. | KYMR | Mainolfi Nello CEO | 6,706 | $0 | 606,686 (Direct) | View |
| 2021-08-03 Exercise | 2021-08-05 4:14 pm | N/A N/A | Kymera Therapeutics Inc. | KYMR | Mainolfi Nello CEO | 6,706 | $2.08 | 606,686 (Direct) | View |
| 2021-07-29 Exercise | 2021-08-02 5:53 pm | N/A 2029-11-13 | Kymera Therapeutics Inc. | KYMR | Mainolfi Nello CEO | 30,415 | $0 | 755,683 (Direct) | View |
| 2021-07-29 Exercise | 2021-08-02 5:53 pm | N/A N/A | Kymera Therapeutics Inc. | KYMR | Mainolfi Nello CEO | 30,415 | $2.08 | 755,683 (Direct) | View |
| 2021-07-26 Exercise | 2021-07-28 4:57 pm | N/A 2029-11-13 | Kymera Therapeutics Inc. | KYMR | Mainolfi Nello CEO | 12,879 | $0 | 683,755 (Direct) | View |
| 2021-07-26 Exercise | 2021-07-28 4:57 pm | N/A N/A | Kymera Therapeutics Inc. | KYMR | Mainolfi Nello CEO | 12,879 | $2.08 | 683,755 (Direct) | View |
| 2021-07-08 Exercise | 2021-07-09 4:30 pm | N/A 2029-11-13 | Kymera Therapeutics Inc. | KYMR | Mainolfi Nello CEO | 48,000 | $0 | 578,924 (Direct) | View |
| 2021-07-08 Exercise | 2021-07-09 4:30 pm | N/A N/A | Kymera Therapeutics Inc. | KYMR | Mainolfi Nello CEO | 48,000 | $2.08 | 578,924 (Direct) | View |
| 2021-06-21 Option Award | 2021-06-21 5:36 pm | N/A 2031-06-20 | Kymera Therapeutics Inc. | KYMR | Caughey Elaine Chief Business Officer | 100,000 | $0 | 100,000 (Direct) | View |
| 2021-06-16 Option Award | 2021-06-21 4:19 pm | N/A 2031-06-15 | Kymera Therapeutics Inc. | KYMR | BVF PARTNERS L P BIOTECHNOLOGY VALUE FUND L P BVF I GP LLC BIOTECHNOLOGY VALUE FUND II LP BVF II GP LLC Biotechnology Value Trading Fund OS LP BVF Partners OS Ltd. BVF GP HOLDINGS LLC BVF INC LAMPERT MARK N See Remarks | 20,063 | $0 | 2,617,687 (Indirect) | View |
| 2021-06-16 Option Award | 2021-06-17 4:51 pm | N/A 2031-06-15 | Kymera Therapeutics Inc. | KYMR | Nicholson Donald William Director | 20,063 | $0 | 20,063 (Direct) | View |
| 2021-06-16 Option Award | 2021-06-17 4:50 pm | N/A 2031-06-15 | Kymera Therapeutics Inc. | KYMR | Esposito Pamela Director | 20,063 | $0 | 20,063 (Direct) | View |
| 2021-06-16 Option Award | 2021-06-17 4:49 pm | N/A 2031-06-15 | Kymera Therapeutics Inc. | KYMR | Ridloff Elena Director | 20,063 | $0 | 20,063 (Direct) | View |